Bausch Health Companies | VRX - Gross Profit On Sales


Bausch Health Companies reported $2.08B in Gross Profit on Sales for its fiscal quarter ending in June of 2026.





Gross Profit On Sales Change Date
Amgen USD 5.87B 1.02B Mar/2026
ANI Pharmaceuticals USD 143.88M 19.7M Mar/2026
Aurora Cannabis CAD 29.79M 16.83M Mar/2026
Bausch Health Companies USD 2.08B 294M Jun/2026
Biogen USD 2.12B 307M Jun/2026
Bristol-Myers Squibb USD 9.26B 1.19B Jun/2026
Canopy Growth CAD 8.26M 13.2M Mar/2026
Corcept Therapeutics USD 252.09M 90.07M Jun/2026
Danaher USD 3.61B 20M Jun/2026
Drreddys Laboratories INR 43.04B 3.77B Mar/2026
Eli Lilly USD 16.22B 301.7M Mar/2026
Gilead Sciences USD 6.8B 1.29B Jun/2026
Nektar Therapeutics USD 10.86M 10.95M Mar/2026
Novo Nordisk DKK 64.01B 1.19B Jun/2025
Pacira USD 133.91M 7.27M Jun/2026
Perrigo USD 313.9M 11.6M Jun/2026
Phibro Animal Health USD 133.5M 12.6M Dec/2025
Prestige Brands USD 136.19M 10.11M Jun/2026
Supernus Pharmaceuticals USD 160.06M 30.7M Jun/2026
Vertex Pharmaceuticals USD 2.84B 242.4M Jun/2026
Zoetis USD 1.76B 140M Jun/2026